The Effect of Ki-67 Expression on the Clinical Efficacy of Neoadjuvant Chemotherapy with AC-T Chemo-Therapy for Locally Advanced Breast Cancer

CHEN Da-qin,CAO Yong,ZHENG Xiao-dong,NIAN Wei-qi,ZENG Xiao-hua,LIU Xiao-yu

DOI: https://doi.org/10.12037/yxqy.2017.06-24

2017-01-01

Abstract:Objective To investigate the effect of Ki-67 expression on the clinical efficacy of neoadjuvant chemotherapy with pirarubicin and cyclophosphamide sequential docetaxel (AC-T) chemotherapy for locally advanced breast cancer (LABC), and to provide a reference for early prediction of neoadjuvant chemotherapy. Method 233 cases of patients with LABC admitted in our hospital from February 2013 to February 2016 were selected as the research objects. All patients were treated with AC-T regimen neoadjuvant chemotherapy, according to whether the patients getting pathological complete remission (pCR) after chemotherapy, they were divided into pCR group and non-pCR group. The general information and Ki-67 expression in lesion tissue were compared to analyse the factors influencing the clinical effect of LABC patients, and detected the changes of the expression of Ki-67 in lesion tissues before and after chemotherapy. Result In 233 cases, 122 cases of patients wtih complete response (including 53 cases wirth pCR), 83 cases with partial response, 15 cases with stable disease, 13 cases with rogressive disease, total effective rate was 87.98%, breast conserving rate was 12.88% (30/233). Multivariate analysis showed that over expression of HER-2 molecular classification and high expression of Ki-67 before chemotherapy were protective factors affecting the efficacy of chemotherapy in LABC (P < 0.05). Compared with before chemotherapy, high expression rate of Ki-67 in both pCR group and non-pCR group all decreased, but the positive rate of Ki-67 in non-pCR group was significantly lower than that in pCR group (P < 0.05). Conclusion The clinical effect of AC-T regimen neoadjuvant chemotherapy for LABC patients is affected by molecular type and the expression of Ki-67. High expression of Ki-67 in patients means a better prognosis. But Ki-67 high expression rate decreases after chemotherapy, and the specific mechanism needs to be further discussed.